Commercial, Energy Efficiency, GHG Emissions - February 6, 2024
Cardinal Health Lowers Emissions by 13%
Cardinal Health lowered its Scope 1 and Scope 2 GHG emissions by 13% from a fiscal 2019 base year, achieving progress toward its fiscal 2030 50% reduction goal.
Cardinal Health, a pharmaceutical company that manufactures and distributes medical and laboratory products, in addition to providing performance and data solutions for healthcare facilities, also baselined its Scope 3 GHG emissions and submitted a science-based target that includes Scope 1, 2, and 3 emissions to the Science Based Targets initiative (SBTi) for validation.
The company expects to provide more detail in the coming months.
Cardinal Health also conducted its first life cycle assessment (LCA) comparing single-use compression sleeves to reprocessed alternatives in its Sustainable Technologies™ business: results showed that reprocessed sleeves had a 40% lower carbon footprint and reduced hospital waste disposal costs by 90%.
The company also continued to improve its supplier due diligence program and supply chain mapping to increase transparency and business integrity throughout its supply chain.
Cardinal Health's latest ESG Report was prepared in accordance with the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB), and the Task Force on Climate-related Financial Disclosures (TCFD) frameworks.
Details were released in its Fiscal 2023 Environmental, Social, and Governance (ESG) Report.
"At Cardinal Health, we approach ESG in a way that supports our business, positions us as a partner of choice for customers and suppliers, and ensures compliance with evolving regulatory requirements," said Jason Hollar, Cardinal Health's CEO, in a statement. "We know that ESG is the right thing to do and the right thing for our business. Our new report illustrates how our ESG priorities are helping us create long-term, sustainable value for all our stakeholders."
Read These Related Articles:
Stay Up-To-Date
